Síndrome de degeneración combinada de la médula espinal y radiculopatía en dos pacientes por quimioterapia intratecal con metrotrexato y citarabina. Casos clínicos
Intrathecal chemotherapy may be complicated with the development of myelopathies or toxic radiculopathies. This myeloradicular involvement, of toxic character, is unpredictable, since these patients have repeatedly received Intrathecal chemotherapy with the same drugs without apparent injury. The to...
Guardado en:
Autores principales: | , , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2018
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018000600802 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872018000600802 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720180006008022018-08-24Síndrome de degeneración combinada de la médula espinal y radiculopatía en dos pacientes por quimioterapia intratecal con metrotrexato y citarabina. Casos clínicosCartier R.,LuisParra V.,JorgePuga,BárbaraCardemil,Daniela Cytarabine Drug Therapy Meningeal Neoplasms Subacute Combined Degeneration Intrathecal chemotherapy may be complicated with the development of myelopathies or toxic radiculopathies. This myeloradicular involvement, of toxic character, is unpredictable, since these patients have repeatedly received Intrathecal chemotherapy with the same drugs without apparent injury. The toxic effect should be mainly attributed to Cytarabine and not to methotrexate, since the central nervous system lacks Cytidine deaminase, the enzyme that degrades Cytarabine. We report two patients, an 18-year-old woman and a 16 years old male, who received systemic and intrathecal chemotherapy (methotrexate, cytarabine) for the treatment of an acute lymphoblastic leukemia and developed, in relation to this procedure, a spinal subacute combined degeneration. They had a proprioceptive and motor alteration of the lower extremities and neuroimaging showed selective rear and side spinal cord hyper intensity produced by central axonopathy. Two weeks later the woman developed a quadriplegia and the young man a flaccid paraplegia due to added root involvement.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.146 n.6 20182018-06-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018000600802es10.4067/s0034-98872018000600802 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Cytarabine Drug Therapy Meningeal Neoplasms Subacute Combined Degeneration |
spellingShingle |
Cytarabine Drug Therapy Meningeal Neoplasms Subacute Combined Degeneration Cartier R.,Luis Parra V.,Jorge Puga,Bárbara Cardemil,Daniela Síndrome de degeneración combinada de la médula espinal y radiculopatía en dos pacientes por quimioterapia intratecal con metrotrexato y citarabina. Casos clínicos |
description |
Intrathecal chemotherapy may be complicated with the development of myelopathies or toxic radiculopathies. This myeloradicular involvement, of toxic character, is unpredictable, since these patients have repeatedly received Intrathecal chemotherapy with the same drugs without apparent injury. The toxic effect should be mainly attributed to Cytarabine and not to methotrexate, since the central nervous system lacks Cytidine deaminase, the enzyme that degrades Cytarabine. We report two patients, an 18-year-old woman and a 16 years old male, who received systemic and intrathecal chemotherapy (methotrexate, cytarabine) for the treatment of an acute lymphoblastic leukemia and developed, in relation to this procedure, a spinal subacute combined degeneration. They had a proprioceptive and motor alteration of the lower extremities and neuroimaging showed selective rear and side spinal cord hyper intensity produced by central axonopathy. Two weeks later the woman developed a quadriplegia and the young man a flaccid paraplegia due to added root involvement. |
author |
Cartier R.,Luis Parra V.,Jorge Puga,Bárbara Cardemil,Daniela |
author_facet |
Cartier R.,Luis Parra V.,Jorge Puga,Bárbara Cardemil,Daniela |
author_sort |
Cartier R.,Luis |
title |
Síndrome de degeneración combinada de la médula espinal y radiculopatía en dos pacientes por quimioterapia intratecal con metrotrexato y citarabina. Casos clínicos |
title_short |
Síndrome de degeneración combinada de la médula espinal y radiculopatía en dos pacientes por quimioterapia intratecal con metrotrexato y citarabina. Casos clínicos |
title_full |
Síndrome de degeneración combinada de la médula espinal y radiculopatía en dos pacientes por quimioterapia intratecal con metrotrexato y citarabina. Casos clínicos |
title_fullStr |
Síndrome de degeneración combinada de la médula espinal y radiculopatía en dos pacientes por quimioterapia intratecal con metrotrexato y citarabina. Casos clínicos |
title_full_unstemmed |
Síndrome de degeneración combinada de la médula espinal y radiculopatía en dos pacientes por quimioterapia intratecal con metrotrexato y citarabina. Casos clínicos |
title_sort |
síndrome de degeneración combinada de la médula espinal y radiculopatía en dos pacientes por quimioterapia intratecal con metrotrexato y citarabina. casos clínicos |
publisher |
Sociedad Médica de Santiago |
publishDate |
2018 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018000600802 |
work_keys_str_mv |
AT cartierrluis sindromededegeneracioncombinadadelamedulaespinalyradiculopatiaendospacientesporquimioterapiaintratecalconmetrotrexatoycitarabinacasosclinicos AT parravjorge sindromededegeneracioncombinadadelamedulaespinalyradiculopatiaendospacientesporquimioterapiaintratecalconmetrotrexatoycitarabinacasosclinicos AT pugabarbara sindromededegeneracioncombinadadelamedulaespinalyradiculopatiaendospacientesporquimioterapiaintratecalconmetrotrexatoycitarabinacasosclinicos AT cardemildaniela sindromededegeneracioncombinadadelamedulaespinalyradiculopatiaendospacientesporquimioterapiaintratecalconmetrotrexatoycitarabinacasosclinicos |
_version_ |
1718437011801505792 |